Immunovant, Inc. (IMVT) SEC Filings https://www.immunovant.com/investors/sec-filings/annual-reports/rss Immunovant, Inc. (IMVT) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg Immunovant, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[ARS - Annual Report to Security Holders]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-25-000105/0001764013-25-000105.pdf Wed, 09 Jul 25 16:58:25 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-25-000105/0001764013-25-000105.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-25-000092/0001764013-25-000092.pdf Thu, 29 May 25 07:31:10 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-25-000092/0001764013-25-000092.pdf <![CDATA[ARS - Annual report to security holders]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-24-000121/0001764013-24-000121.pdf Fri, 28 Jun 24 16:10:17 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-24-000121/0001764013-24-000121.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-24-000109/0001764013-24-000109.pdf Wed, 29 May 24 16:36:52 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-24-000109/0001764013-24-000109.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-23-000065/0001764013-23-000065.pdf Mon, 22 May 23 07:12:00 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-23-000065/0001764013-23-000065.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-22-000059/0001764013-22-000059.pdf Wed, 08 Jun 22 07:10:13 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-22-000059/0001764013-22-000059.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-21-000052/0001764013-21-000052.pdf Mon, 12 Jul 21 19:14:25 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-21-000052/0001764013-21-000052.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0000950123-20-006444/0000950123-20-006444.pdf Mon, 12 Jul 21 17:21:50 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0000950123-20-006444/0000950123-20-006444.pdf